Cite
HARVARD Citation
Hachulla, E. et al. (2017). High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance. International journal of neuroscience. pp. 516-523. [Online].